VZA-29576-14395
3 vaccinations
1 coded response
35 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 786 / TX
- Registered
- 2021-01-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-29
Registered in v-safe
-
2021-01-29
Dose 1 — Moderna
- 2021-01-29
-
2021-01-30
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-05
- 2021-02-14
- 2021-02-19
- 2021-02-28
- 2021-03-05
-
2021-03-06
Dose 2 — Moderna
- 2021-03-06
-
2021-03-07
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-08
- 2021-03-10
- 2021-03-11
- 2021-03-12
- 2021-03-13
- 2021-03-20
- 2021-03-27
- 2021-04-03
- 2021-04-10
- 2021-04-17
- 2021-06-05
- 2021-09-04
-
2021-12-17
Dose 3 — Moderna
-
2021-12-22
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Swelling · HeadacheAdult check-in
- 2021-12-26
- 2022-01-07
- 2022-01-14
- 2022-01-21
- 2022-01-28
- 2022-03-18
- 2022-06-17
-
2022-12-17
Survey response — 12 months, dose 3MedDRA: Diabetes mellitus, Office visit — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Diabetes · Healthcare visit (other): DrMedDRA releases: 2024-11 · check-in free text available
-
2022-12-17
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professional1 call case(s)
-
2022-12-20
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-29 | Moderna | |
| 2 | 2021-03-06 | Moderna | |
| 3 | 2021-12-17 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-12-17 | Successful 2022-12-20 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 12 — 12 months, dose 3
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Diabetes mellitus | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release